Lemon Tree Hotels gets NSE no-objection, BSE no adverse observations on scheme
Lemon Tree Hotels Ltd · Leisure Services
What the filing says
- NSE gave 'no objection' and BSE gave 'no adverse observations' on the draft Composite Scheme of Arrangement; the company received both on September 22, 2026.
- The scheme involves Lemon Tree Hotels Limited, Fleur Hotels Limited (Transferee Company) and six transferor companies, starting with Carnation Hotels Private Limited.
- The observation letters are valid for six months from September 22, 2026, within which the scheme must be submitted to NCLT; NCLT, shareholder and creditor approvals are still needed.
Why it's rated notable: merger demerger is always high
Figures checked against the filing by a second AI read, which corrected the first summary. About the business, not the share price.
Original filing
Announcement under Regulation 30 (LODR)-Scheme of Arrangement
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Electrical Equipment
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Other acquisition / merger filings this fortnight
- Acquisition / mergerSwelect EnergySwelect Energy Systems to acquire 100% shares of Sushma Solar Energy Pvt Ltd
- Acquisition / mergerUgro Capital LtdUGRO Capital Ltd announces NCLT hearing date for amalgamation scheme with Profectus
- Acquisition / mergerCyient LtdCyient Limited announces Q2 and H1 FY27 financial results and corporate updates
- Acquisition / mergerSagilitySagility Limited reports Q2 FY27 financial results and declares interim dividend
- Acquisition / mergerShyam Metalics & Energy LtdShyam Sel and Power Ltd seeks NCLT approval for scheme to amalgamate Shree Venkateshwara Electrocast Pvt Ltd
- Acquisition / mergerPetronet LNG LtdPetronet LNG signs binding term sheet with Gruner Renewable for CBG JV
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.